ZURICH (Reuters) – Novartis has agreed with Ionis Pharmaceuticals Inc and its affiliate Akcea Therapeutics Inc to license two experimental cardiovascular treatments in a deal which Ionis said could eventually be worth more than $1 billion.
Global: Christine Lagarde, I.M.F. Chief, on trial in France over misuse of public money
The New York Times
Christine Lagarde, the managing director of the International Monetary Fund, went on trial in Paris on Monday, facing criminal charges of negligence resulting in the misuse of hundreds of millions of euros in public money when she was France’s finance minister.
South Korea: Former South Korean prosecutor gets 4 years for corruption
A South Korean court on Tuesday sentenced a former senior prosecutor to four years in prison for pressuring a Korean Air executive to channel about 14.7 billion won ($12 million) in corporate deals to a contractor run by his brother-in-law.
Brazil: Brazil presidential adviser resigns amid reports of corruption
The Wall Street Journal
An adviser to Brazilian President Michel Temer resigned Wednesday amid media reports he accepted illegal payments from construction company Odebrecht SA, another blow to the embattled chief executive as he works to push unpopular economic reforms through Congress.
Israeli authorities placed billionaire businessman Beny Steinmetz under house arrest on Monday over allegations of bribery and corruption in Africa linked to his mining company, BSG Resources (BSGR).